Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to …
RM Tuttle, H Tala, J Shah, R Leboeuf, R Ghossein… - Thyroid, 2010 - liebertpub.com
Background: A risk-adapted approach to management of thyroid cancer requires risk
estimates that change over time based on response to therapy and the course of the …
estimates that change over time based on response to therapy and the course of the …
Dynamic risk stratification for predicting recurrence in patients with differentiated thyroid cancer treated without radioactive iodine remnant ablation therapy
S Park, WG Kim, E Song, HS Oh, M Kim, H Kwon… - Thyroid, 2017 - liebertpub.com
Background: Increased incidence of small differentiated thyroid cancer (DTC) has
emphasized the need for risk stratification and individualized disease management for these …
emphasized the need for risk stratification and individualized disease management for these …
Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease …
F Vaisman, A Shaha, S Fish… - Clinical …, 2011 - Wiley Online Library
Objective To describe the risk of structural disease recurrence in a cohort of patients with
differentiated thyroid cancer selected for treatment with either thyroid lobectomy or total …
differentiated thyroid cancer selected for treatment with either thyroid lobectomy or total …
Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine
DP Momesso, F Vaisman, SP Yang… - The Journal of …, 2016 - academic.oup.com
Context: Although response to therapy assessment is a validated tool for dynamic risk
stratification in patients with differentiated thyroid cancer (DTC) treated with total …
stratification in patients with differentiated thyroid cancer (DTC) treated with total …
The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering …
Background: The American Thyroid Association guidelines recommend the routine use of
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
A joint statement from the American thyroid association, the European association of nuclear medicine, the European thyroid association, the society of nuclear …
Background: The American Thyroid Association (ATA), the European Association of Nuclear
Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and …
Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and …
Radioiodine ablation following thyroidectomy for differentiated thyroid cancer: literature review of utility, dose, and toxicity
NS Andresen, JM Buatti, HH Tewfik… - European thyroid …, 2017 - etj.bioscientifica.com
Management recommendations for differentiated thyroid cancer are evolving. Total
thyroidectomy is the backbone of curative-intent therapy, with radioiodine ablation (RAI) of …
thyroidectomy is the backbone of curative-intent therapy, with radioiodine ablation (RAI) of …
Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American Thyroid Association and Latin American Thyroid Society risk of …
F Pitoia, F Bueno, C Urciuoli, E Abelleira, G Cross… - Thyroid, 2013 - liebertpub.com
Objectives: The aims of this study were to validate the proposed Latin American Thyroid
Society (LATS) risk of recurrence stratification system and to compare the findings with those …
Society (LATS) risk of recurrence stratification system and to compare the findings with those …
Evaluating the 2015 American Thyroid Association risk stratification system in high-risk papillary and follicular thyroid cancer patients
EFS van Velsen, MT Stegenga, FJ van Kemenade… - Thyroid, 2019 - liebertpub.com
Background: The 2015 American Thyroid Association (ATA) Risk Stratification System for
differentiated thyroid cancer (DTC) is designed to predict recurring/persisting disease but not …
differentiated thyroid cancer (DTC) is designed to predict recurring/persisting disease but not …
Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients
C Schvartz, F Bonnetain, S Dabakuyo… - The Journal of …, 2012 - academic.oup.com
Context: American Thyroid Association and European Thyroid Association guidelines
cannot recommend for or against radioactive iodine (RAI) ablation after surgery in low-risk …
cannot recommend for or against radioactive iodine (RAI) ablation after surgery in low-risk …
相关搜索
- differentiated thyroid cancer patients
- thyroid cancer radioactive iodine
- thyroidectomy for differentiated thyroid cancer
- differentiated thyroid cancer outcomes
- follicular thyroid cancer patients
- thyroid cancer recurrence in the management
- thyroid cancer radioiodine ablation
- thyroid cancer outcomes of patients
- thyroid cancer risk stratification
- thyroid cancer sloan kettering
- thyroid cancer selective use
- american thyroid association risk
- thyroid cancer recurrence in patients
- management of papillary thyroid cancer
- recurrence in the management radioactive iodine
- risk stratification radioactive iodine